{
    "2021-04-12": [
        [
            {
                "time": "",
                "original_text": "高瓴资本概念股普遍下滑，公牛集团、泰格医药、健帆生物、凯莱英领跌",
                "features": {
                    "keywords": [
                        "高瓴资本",
                        "概念股",
                        "下滑",
                        "公牛集团",
                        "泰格医药",
                        "健帆生物",
                        "凯莱英"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "消费"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "中泰金工定向增发跟踪周报（04/11）",
                "features": {
                    "keywords": [
                        "中泰金工",
                        "定向增发",
                        "周报"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药与健康护理行业周报：年报一季报相继披露 看好业绩确定性高的医药白马",
                "features": {
                    "keywords": [
                        "医药",
                        "健康护理",
                        "年报",
                        "一季报",
                        "业绩确定性",
                        "白马"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业：医药企业国际化的的一些思考",
                "features": {
                    "keywords": [
                        "医药生物",
                        "国际化",
                        "思考"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}